Maine Revised Statutes
Subchapter 9: MISCELLANEOUS PROVISIONS
32 §13800. Access to distributed drugs

§13800. Access to distributed drugs
A manufacturer or wholesaler licensed under section 13758 shall make a drug distributed in this State available for sale in this State to an eligible product developer for purposes of conducting testing required to support an application for approval of a drug under the Federal Food, Drug, and Cosmetic Act, Section 505(b) or 505(j) or the licensing of a biological product under the federal Public Health Service Act, Section 351.   [PL 2017, c. 434, §5 (NEW).]
The manufacturer or wholesaler licensed under section 13758 shall make the drug available for sale at a price no greater than the wholesale acquisition cost and without any restriction that would block or delay the eligible product developer's application in a manner inconsistent with Section 505‑1(f)(8) of the Federal Food, Drug, and Cosmetic Act, 21 United States Code, Section 355‑1(f)(8) (2016).   [PL 2017, c. 434, §5 (NEW).]
An eligible product developer that receives a drug at a price no greater than the wholesale acquisition cost for that drug pursuant to this section shall charge consumers in this State the same price or less for the drug manufactured by that eligible product developer.   [PL 2017, c. 434, §5 (NEW).]
As used in this section, "wholesale acquisition cost" means the manufacturer's list price for a brand-name drug or a generic drug per person per year or course of treatment when sold to wholesalers or direct purchasers in the United States, not including discounts or rebates, for the most recent month for which information is available.   [PL 2017, c. 434, §5 (NEW).]
SECTION HISTORY
PL 2017, c. 434, §5 (NEW).

Structure Maine Revised Statutes

Maine Revised Statutes

TITLE 32: PROFESSIONS AND OCCUPATIONS

Chapter 117: MAINE PHARMACY ACT

Subchapter 9: MISCELLANEOUS PROVISIONS

32 §13781. Generic and therapeutically equivalent substitution

32 §13782. Advertising

32 §13782-A. Price disclosure

32 §13783. Posting prices (REPEALED)

32 §13784. Patient information regulation

32 §13785. Patient profile record system regulation

32 §13786. Identification of persons prescribing medicines on hospital prescription blanks

32 §13786-A. Security requirements; rules

32 §13786-B. Partial dispensing of prescription for opioid medication

32 §13786-C. Dispensing of prescription of opioid medication; immunity

32 §13786-D. Prescribing and dispensing insulin

32 §13786-E. Prescribing, dispensing and administering HIV prevention drugs

32 §13786-F. Dispensing of emergency supplies of chronic maintenance drug

32 §13787. Hypodermic syringes; prescriptions (REPEALED)

32 §13787-A. Sale of hypodermic apparatus

32 §13788. Sale of poisonous drugs

32 §13789. Possession of drug samples

32 §13790. Using drugs not in prescription

32 §13791. Return of drugs

32 §13792. Sale by certain methods prohibited

32 §13793. Adulterating and selling drugs

32 §13794. Labeling of prescriptions

32 §13795. Photographic proof of identification; discretion to sell or dispense; immunity

32 §13796. Retail sale of targeted methamphetamine precursors

32 §13797. Prescription drug price information

32 §13798. Expedited partner therapy

32 §13799. Consumer choice preserved

32 §13800. Access to distributed drugs

32 §13800-A. Liability for product of another; exemption

32 §13800-B. Prohibition on providing conversion therapy to minors

32 §13800-C. Opioid medication product registration fee

32 §13800-D. Insulin product registration fee (WHOLE SECTION TEXT EFFECTIVE UNTIL 1/01/27) (WHOLE SECTION TEXT REPEALED 1/01/27)